Sativex® launched in Germany for MS spasticity

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Sativex® launched in Germany for MS spasticity

Postby MSUK » Mon Jul 04, 2011 1:16 am


GW Pharmaceuticals plc today announces the launch in Germany of Sativex® (Delta-9-Tetrahydro-cannabinol (THC) and Cannabidiol (CBD)) oromucosal spray as a treatment of spasticity due to Multiple Sclerosis (MS). This launch follows regulatory approval of Sativex®by the German health authorities in May. Germany has the highest prevalence of MS in Europe.

Sativex® is a first in class endocannabinoid system modulator and is delivered by an oromucosal spray (sprayed into the mouth either onto the inside of the cheek or under the tongue). Sativex®offers the first new therapeutic option in decades to patients in Germany who have previously failed to respond adequately to other anti-spasticity medication. The spray is quickly absorbed through the oral mucosa, is easy to use for patients and enables them to optimally adjust their dosage. The medicine is already available for MS patients in the UK and Spain.... Read More - ... ageid/1814
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: Scott1

Contact us | Terms of Service